B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
about
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammationChronic Lyme borreliosis associated with minimal change glomerular disease: a case report.Minimal-Change Disease Secondary to Borrelia burgdorferi Infection.Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection.
P2860
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
@ast
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
@en
type
label
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
@ast
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
@en
prefLabel
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
@ast
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis.
@en
P2093
P2860
P1476
B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis
@en
P2093
S W Barthold
P2860
P304
P407
P577
1997-08-01T00:00:00Z